Tibet AIM Pharm. Inc. (002826.SZ)

CNY 9.04

(-9.87%)

Revenue Summary of Tibet AIM Pharm. Inc.

  • Tibet AIM Pharm. Inc.'s latest annual revenue in 2023 was 667.03 Million CNY , down -22.14% from previous year.
  • Tibet AIM Pharm. Inc.'s latest quarterly revenue in 2024 Q3 was 158.42 Million CNY , down -14.69% from previous quarter.
  • Tibet AIM Pharm. Inc. reported a annual revenue of 856.73 Million CNY in annual revenue 2022, up 18.1% from previous year.
  • Tibet AIM Pharm. Inc. reported a annual revenue of 725.45 Million CNY in annual revenue 2021, up 20.38% from previous year.
  • Tibet AIM Pharm. Inc. reported a quarterly revenue of 158.42 Million CNY for 2024 Q3, down -14.69% from previous quarter.
  • Tibet AIM Pharm. Inc. reported a quarterly revenue of 160.42 Million CNY for 2024 Q1, up 24.61% from previous quarter.

Annual Revenue Chart of Tibet AIM Pharm. Inc. (2023 - 2013)

Historical Annual Revenue of Tibet AIM Pharm. Inc. (2023 - 2013)

Year Revenue Revenue Growth
2023 667.03 Million CNY -22.14%
2022 856.73 Million CNY 18.1%
2021 725.45 Million CNY 20.38%
2020 602.61 Million CNY 8.92%
2019 553.25 Million CNY 13.19%
2018 488.77 Million CNY 28.53%
2017 380.29 Million CNY -15.85%
2016 451.92 Million CNY 30.24%
2015 346.99 Million CNY 19.35%
2014 290.72 Million CNY 31.49%
2013 221.1 Million CNY 0.0%

Peer Revenue Comparison of Tibet AIM Pharm. Inc.

Name Revenue Revenue Difference
Shenzhen Neptunus Bioengineering Co., Ltd. 36.41 Billion CNY 98.168%
Anhui Fengyuan Pharmaceutical Co., Ltd. 4.27 Billion CNY 84.398%
Dong-E-E-Jiao Co.,Ltd. 4.71 Billion CNY 85.854%
Livzon Pharmaceutical Group Inc. 12.27 Billion CNY 94.567%
Hainan Haiyao Co., Ltd. 1.45 Billion CNY 54.225%
Tus-Pharmaceutical Group Co., Ltd. 395.92 Million CNY -68.477%
Jilin Aodong Pharmaceutical Group Co., Ltd. 3.44 Billion CNY 80.661%
Changchun High-Tech Industries (Group) Inc. 14.46 Billion CNY 95.387%
Apeloa Pharmaceutical Co.,Ltd 11.47 Billion CNY 94.187%
PKU HealthCare Corp.,Ltd. 2.19 Billion CNY 69.594%
Chengdu Huasun Technology Group Inc., Ltd. 1 Billion CNY 33.521%
Dezhan Healthcare Company Limited 498.08 Million CNY -33.92%
Jinling Pharmaceutical Company Limited 2.78 Billion CNY 76.055%
Jiuzhitang Co., Ltd. 2.91 Billion CNY 77.151%
Huapont Life Sciences Co., Ltd. 11.59 Billion CNY 94.247%
Zhejiang Jingxin Pharmaceutical Co., Ltd. 3.95 Billion CNY 83.122%
Shandong Wohua Pharmaceutical Co., Ltd. 894.31 Million CNY 25.413%
Hengkang Medical Group Co., Ltd. 3.59 Billion CNY 81.422%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 2.61 Billion CNY 74.448%
Qianjiang Yongan Pharmaceutical Co., Ltd. 962.8 Million CNY 30.719%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 5.42 Billion CNY 87.697%
Jinhe Biotechnology CO., LTD. 2.17 Billion CNY 69.319%
Teyi Pharmaceutical Group Co.,Ltd 1.06 Billion CNY 37.497%
Kunming Longjin Pharmaceutical Co., Ltd. 86.62 Million CNY -670.053%
Beijing Aosaikang Pharmaceutical Co., Ltd. 1.44 Billion CNY 53.789%
Chengdu Kanghong Pharmaceutical Group Co., Ltd 3.95 Billion CNY 83.145%
Anhui Huangshan Capsule Co., Ltd. 458.36 Million CNY -45.524%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd 980.82 Million CNY 31.992%
Zhuhai Rundu Pharmaceutical Co., Ltd. 1.29 Billion CNY 48.367%
Huaren Pharmaceutical Co., Ltd. 1.63 Billion CNY 59.234%
Tianjin Ringpu Bio-Technology Co.,Ltd. 2.24 Billion CNY 70.34%
Shanxi Zhendong Pharmaceutical Co.,Ltd 3.62 Billion CNY 81.604%
Fuan Pharmaceutical (Group) Co., Ltd. 2.64 Billion CNY 74.807%
Hybio Pharmaceutical Co., Ltd. 431.38 Million CNY -54.628%
Baotou Dongbao Bio-Tech Co.,Ltd 974.51 Million CNY 31.551%
Hunan Er-Kang Pharmaceutical Co., Ltd 1.76 Billion CNY 62.297%
Changjiang Pharmaceutical Group Co., Ltd. 1.19 Billion CNY 44.3%
Zhejiang Garden Bio-chemical High-tech Co., Ltd. 1.09 Billion CNY 39.064%
Fujian Cosunter Pharmaceutical Co., Ltd. 422.71 Million CNY -57.799%
Beijing Science Sun Pharmaceutical Co., Ltd. 476.56 Million CNY -39.967%
Zhejiang Xinguang Pharmaceutical Co., Ltd. 270.39 Million CNY -146.686%
Hainan Poly Pharm. Co., Ltd 1.3 Billion CNY 48.866%
Jiangxi Synergy Pharmaceutical Co., Ltd. 722.13 Million CNY 7.63%
Wuhan Hiteck Biological Pharma Co.,Ltd 602.28 Million CNY -10.752%
Shandong Xinhua Pharmaceutical Company Limited 8 Billion CNY 91.671%
Zhejiang Tianyu Pharmaceutical Co., Ltd. 2.52 Billion CNY 73.606%
PharmaBlock Sciences (Nanjing), Inc. 1.72 Billion CNY 61.336%
Jinghua Pharmaceutical Group Co., Ltd. 1.49 Billion CNY 55.246%
Zhejiang Hisoar Pharmaceutical Co., Ltd. 2.17 Billion CNY 69.288%
Betta Pharmaceuticals Co., Ltd. 2.45 Billion CNY 72.843%
Shenzhen Kangtai Biological Products Co., Ltd. 3.47 Billion CNY 80.818%
Shandong Shanda Wit Science and Technology Co., Ltd. 2.48 Billion CNY 73.148%
Pacific Shuanglin Bio-pharmacy Co., LTD 2.32 Billion CNY 71.356%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. 1.62 Billion CNY 58.973%
Xiamen Kingdomway Group Company 3.1 Billion CNY 78.501%
ShanXi C&Y Pharmaceutical Group Co., Ltd. 799.3 Million CNY 16.548%
Walvax Biotechnology Co., Ltd. 4.11 Billion CNY 83.785%
Sunflower Pharmaceutical Group Co.,Ltd 5.63 Billion CNY 88.156%
Harbin Gloria Pharmaceuticals Co., Ltd 2.58 Billion CNY 74.245%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 24.73 Billion CNY 97.304%
Hunan Hansen Pharmaceutical Co., Ltd. 955.53 Million CNY 30.192%
Changzhou Qianhong Biopharma CO.,LTD 1.79 Billion CNY 62.816%
Shenzhen Weiguang Biological Products Co., Ltd. 1.04 Billion CNY 36.382%
Honz Pharmaceutical Co., Ltd. 739.56 Million CNY 9.807%
Northeast Pharmaceutical Group Co., Ltd. 8.16 Billion CNY 91.827%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd 1.46 Billion CNY 54.396%
Guizhou Xinbang Pharmaceutical Co., Ltd. 6.46 Billion CNY 89.676%
Tianjin Lisheng Pharmaceutical Co.,Ltd. 1.13 Billion CNY 40.979%
Zhejiang Yatai Pharmaceutical Co., Ltd. 420.64 Million CNY -58.576%
Zhejiang NHU Company Ltd. 15.11 Billion CNY 95.587%
ApicHope Pharmaceutical Co., Ltd 2.5 Billion CNY 73.355%
Shanghai Kaibao Pharmaceutical CO.,Ltd 1.59 Billion CNY 58.154%
Beijing SL Pharmaceutical Co., Ltd. 1.01 Billion CNY 34.499%
Yunnan Baiyao Group Co.,Ltd 38.9 Billion CNY 98.285%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD 1.08 Billion CNY 38.24%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. 839.25 Million CNY 20.521%
Guangdong Lifestrong Pharmacy Co., Ltd. 292.39 Million CNY -128.128%
Huadong Medicine Co., Ltd 40.39 Billion CNY 98.349%
Jiangsu Nhwa Pharmaceutical Co., LTD 4.97 Billion CNY 86.588%
Harbin Medisan Pharmaceutical Co., Ltd. 1.18 Billion CNY 43.795%
LanZhou Foci Pharmaceutical Co.,Ltd. 1.16 Billion CNY 42.652%
Tianjin Chase Sun Pharmaceutical Co.,Ltd 6.12 Billion CNY 89.114%
Beijing Beilu Pharmaceutical Co., Ltd 890.71 Million CNY 25.112%
Nanjing Hicin Pharmaceutical Co., Ltd. 517.83 Million CNY -28.814%
Renhe Pharmacy Co., Ltd. 5.03 Billion CNY 86.744%
Chongqing Pharscin Pharmaceutical Co., Ltd. 691.54 Million CNY 3.543%
Zhejiang Xianju Pharmaceutical Co.,Ltd. 4.12 Billion CNY 83.823%
Luoxin Pharmaceuticals Group Stock Co., Ltd. 2.34 Billion CNY 71.526%
Guizhou Bailing Group Pharmaceutical Co., Ltd. 4.26 Billion CNY 84.353%